3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
2
Conditions
Neoplasms
4
Motor Activity
3
Head and Neck Neoplasms
3
Breast Neoplasms
3
Pharyngeal Neoplasms
2
Obesity
2
Laryngeal Neoplasms
2
Diabetes Mellitus, Type 2
2
Colonic Neoplasms
2
Weight Loss
1
Sarcopenia
1
Lung Neoplasms
1
Lung Diseases
1
Liver Neoplasms
1
Liver Diseases
1
Gastrointestinal Neoplasms
1
Chronic Disease
1
COVID-19
1
Brain Neoplasms
1
Body Weight Changes
1
Interventions
relacorilant
4
Resistance Training
3
Pioglitazone
3
Dipeptidyl-Peptidase IV Inhibitors
3
Sulfonylurea Compounds
2
Rosiglitazone
2
Nutritional Status
2
Metformin
2
voglibose
1
saxagliptin
1
repaglinide
1
pembrolizumab
1
miglitol
1
metahexamide
1
meglitinide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
empagliflozin
1
Vildagliptin
1
Troglitazone
1
Tolbutamide
1
Tolazamide
1
Thiazolidinediones
1
Surveys and Questionnaires
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sitagliptin Phosphate
1
Resistant Starch
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Diabetes Mellitus, Type 2
×
Nutritional Status
×
Clear all
NCT00697580
2017-03-31
SANO LA
University of Southern California
Phase NA
Completed
104 enrolled
NCT01441323
2017-03-31
STAND
University of Southern California
Phase NA
Completed
62 enrolled